Enovis Corporation

ENOV - Financial Snapshot

Metrics for ENOV

Price $27.32
Shares Outstanding 57.19M
Net Current Assets / Share $-19.75
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $0
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Max Earning Power / Share $-80.54
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-95.11
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 4.75%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Ave Max Earning Power (5Y) $24.22
Ave Max Earning Power (5Q Annualized) $15.74
Ave Max Earning Power Delta (5Q Ann - 5Y) $-8.48
Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Data as of: Price 12-18-25 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 12-19-2025
Income indicators Value Date
EBITDA Positive No 12-19-2025
Net Income Positive No 12-19-2025
Avg CA Burn (Annual %) -52.20% 12-19-2025
Avg CA Burn (Quarterly %) 1.45% 12-19-2025

Shares Outstanding Changes

Date Shares Outstanding Delta
2025-11-10 57,189,381 +29,578
2025-09-17 57,159,803 +3
2025-08-12 57,159,800 +36,700

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.